What happened
ClinicalTrials.gov registry update for Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
SourceClinicalTrials.govclinical updateBiotech
Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
Clinical/translation signal: Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
Factual summary
Why it matters
Clinical trial registry updates are translation signals, not commercialization claims by themselves.
SourceClinicalTrials.govLimitations
ClinicalTrials.gov status does not prove product approval, licensing, revenue, or market adoption.
SourceClinicalTrials.govLinked output
Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumorclinical trialPeople
No reviewed person relationship is attached to this event.
Organizations
Topics
No reviewed topic relationship is attached to this event.
Problems
No reviewed problem relationship is attached to this event.
Relationship evidence
Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor
Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor (NCT05590689)
Timeline
- clinical updateRadiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor